• 목록
• 답변
• 글쓰기
• 게시판 리스트 옵션
  • 수정
  • 삭제

adhd no medication Medication During Pregnancy and Breastfeeding

Women suffering from ADHD have to make a difficult choice about whether to continue or stop taking managing adhd without medication medication during pregnancy and breastfeeding. Little data exists about how long-term exposure to these medications may affect the foetus.

A study recently published in Molecular Psychiatry demonstrates that children exposed to ADHD medication during pregnancy do not develop neurological disorders such as impaired hearing or vision, febrile seizures or IQ impairment. The authors acknowledge that more high quality research is needed.

Risk/Benefit Analysis

Women who are expecting and taking ADHD medication must weigh the benefits of taking it against the potential dangers for the fetus. The doctors don't have the information to provide clear recommendations however they can provide information on risks and adhd medication guide benefits to assist pregnant women to make an informed decision.

A study published in Molecular Psychiatry concluded that women who were taking ADHD medication in early pregnancy were not at greater risk of fetal malformations or structural birth defects. Researchers used a large population-based study of case control to assess the frequency of structural defects that were major in infants born to mothers who took stimulants during pregnancy. Pediatric cardiologists, clinical geneticists and other experts examined the cases to ensure that the classification was correct and to reduce any bias.

However, the study had its limitations. Researchers were unable, in the first place to distinguish the effects triggered by the medication from the disorder. This makes it difficult to know whether the small associations observed in the groups that were exposed result from medication use or the confounding effect of comorbidities. Researchers also did not look at long-term outcomes for offspring.

The study showed that infants whose mother took ADHD medication during pregnancy had a greater risk of being admitted to the neonatal care unit (NICU) in comparison to those whose mothers didn't take any medication during pregnancy, or had discontinued taking their medication prior to or during pregnancy. The reason for this was central nervous system-related disorders and the increased risk for admission was not found to be influenced by which stimulant medications were taken during pregnancy.

Women who took stimulant ADHD medication during pregnancy were also at an elevated chance of having a caesarean birth or having a child with a low Apgar score (less than 7). These increases appear to be unrelated to the type of medication taken during pregnancy.

The research suggests that the risk of a small amount with the use of ADHD medications during early pregnancy could be offset by the higher benefit for both mother and child of continuing treatment for the woman's condition. Physicians should discuss this with their patients and, where possible, assist them in developing strategies to improve coping skills which can reduce the effects of her disorder on her daily functioning and relationships.

Interactions with Medication

As more women than ever are being diagnosed with private adhd medication cost and treated with medication, the question of whether or not to discontinue treatment during pregnancy is one that more and more physicians confront. The majority of these decisions are taken in the absence of clear and authoritative evidence either way, so physicians must weigh their knowledge, the experiences of other doctors, and what the research suggests on the subject and their best judgment for each individual patient.

The issue of risk for infants can be difficult to determine. The research on this issue is based on observations instead of controlled studies and a lot of the results are in conflict. In addition, most studies limit their analysis to live births, which could undervalue the serious teratogenic effects that can lead to abortion or termination of the pregnancy. The study discussed in this journal club addresses these issues by examining data on both live and deceased births.

The conclusion is that while certain studies have demonstrated an association between ADHD medications and the risk of certain birth defects, other studies have found no connection, and most studies show a neutral or even slightly negative impact. In the end an accurate risk-benefit analysis is required in every instance.

It isn't easy, but not impossible for women suffering from ADHD to stop taking their medication. In fact, in an article published in Archives of Women's Mental Health psychologist Jennifer Russell notes that stopping ADHD medication during pregnancy can lead to increased depression, feelings of isolation and family conflict for those suffering from the disorder. Furthermore, a loss of medication may affect the ability to complete job-related tasks and drive safely, which are important aspects of a normal life for a lot of people with ADHD.

She suggests women who are uncertain about whether to continue or stop medication in light of their pregnancy consider educating family members, friends and colleagues about the condition, its effects on daily life, and the benefits of keeping the current treatment plan. It can also help women feel more confident in her decision. It is important to remember that some medications are able to be absorbed through the placenta so if a woman decides to stop her ADHD medication during pregnancy and breastfeeding, she must be aware of the possibility that traces of the drug could be transferred to the child.

Risk of Birth Defects

As the use and use of ADHD drugs to treat symptoms of attention deficit disorder hyperactivity disorder (ADHD) is increasing as does the concern about the potential adverse effects of the drugs on fetuses. A study that was published in the journal Molecular Psychiatry adds to the existing information on this topic. Researchers used two huge data sets to examine over 4.3 million pregnancy and determine if the use of stimulant medications caused birth defects. Researchers discovered that, while the risk overall is low, first-trimester ADHD exposure to medication was associated with slightly higher rates of specific heart defects like ventriculoseptal defects.

The researchers of the study found no link between early medication use and congenital abnormalities such as facial clefting or club foot. The results are in the same vein as previous studies which showed a small, but significant increase in cardiac malformations for women who began taking ADHD medication before the birth of their child. The risk increased in the latter part types of adhd medication pregnancy when a large number of women began to stop taking their medication.

Women who took ADHD medication during the first trimester were more likely require a caesarean birth or have a low Apgar after birth and had a baby that required help breathing after birth. However, the authors of the study were unable to eliminate bias due to selection by limiting the study to women who didn't have any other medical conditions that could be a contributing factor to these findings.

The researchers hope their research will aid in the clinical decisions of doctors who see pregnant women. The researchers recommend that while discussing risks and benefits are crucial, the decision regarding whether or not to stop taking medication should be in light of the severity of each woman's inattentive Adhd medication uk symptoms and her requirements.

The authors caution that, while stopping the medication is an option to look into, it is not recommended due to the high rate depression and other mental problems in women who are expecting or have recently given birth. Additionally, research suggests that women who stop taking their medication will have a difficult adjustment to life without them after the baby is born.

Nursing

The responsibilities of being a new mother can be overwhelming. Women suffering from ADHD may face a lot of challenges when they must deal with their symptoms, go to doctor appointments, prepare for the birth of their child and adjust to new routines. This is why many women choose to continue taking their ADHD medication throughout the pregnancy.

The majority of stimulant drugs are absorbed by breast milk in very small amounts, therefore the risk for nursing infant is very low. The rate of medication exposure will vary based on the dosage and frequency of administration as well as the time of the day. In addition, different drugs enter the infant's system via the gastrointestinal tract or breast milk. The impact of these medications on a newborn's health is not fully comprehended.

Some physicians may discontinue stimulant medication during a woman’s pregnancy due to the absence of research. It's a difficult choice for the woman who must weigh the benefits of her medication against the risk to the embryo. Until more information becomes available, doctors can inquire about pregnant patients if they have an background of ADHD or if they are planning to take medication in the perinatal phase.

Many studies have shown that women can continue to take their ADHD medication in a safe manner during pregnancy and while breast-feeding. As a result, many patients opt to do this and, in consultation with their doctor they have found that the benefits of keeping their current medication far outweigh any risks.

Women who suffer from ADHD who plan to breastfeed should seek the advice of an expert psychiatrist prior to becoming pregnant. They should discuss their medication with their prescriber and discuss the pros and cons for continuing treatment. This includes non medication treatment for adhd adults-pharmacological methods. Psychoeducation is also required to help pregnant women with ADHD understand the symptoms and underlying disorder. They should also be educated about treatment options and reinforce strategies for coping. This should be a multidisciplinary approach, which includes the GP as well as obstetricians, psychiatry and obstetricians. Pregnancy counselling should include the discussion of a plan for management for both mother and child, as well as monitoring for signs of deterioration and when necessary, making adjustments to the medication regimen.